ReviewOrthopadie (Heidelberg, Germany)2023
[10 Years of the German Arthroplasty Registry-EPRD: what has been achieved?]
Review in Orthopadie (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 9 citations in OpenAlex.
- National scale up of PROM based monitoring after joint replacement in Germany.npj health systems · 2026Article
- Fast fix or false hope? Polyethylene exchange in unstable primary unconstrained total knee arthroplasty.Bone & joint open · 2026Article
- Influence of Obesity on Mid-term Revision Rates and Mortality After Elective Total Hip Arthroplasty-Analysis From the German Arthroplasty Registry (EPRD).Arthroplasty today · 2026Article
- Survivorship and risk factors for revision after total hip arthroplasty in patients 30 years and younger: a cohort study from the German arthroplasty register.Acta orthopaedica · 2026Article
- Pooling data for primary total knee implants across national registries: is the same implant used in multiple registries and for the same patient group? An observational study.Acta orthopaedica · 2025Observational
- [Influence of obesity on midterm outcome after primary hip and knee arthroplasty in Germany : Analysis from the EPRD].Orthopadie (Heidelberg, Germany) · 2025Article
- Comparison of Externally Transferred and Self-Recruited Patients with Hip and Knee Revision Arthroplasty at a Certified Maximum-Care Arthroplasty Center (ACmax).Healthcare (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The German Arthroplasty Registry (EPRD) has been accumulating data on hip and knee arthroplasty procedures for 10 years. Even though the EPRD is a voluntary registry, it currently includes more than 2 million documented surgical procedures in Germany. This ranks the EPRD as the third largest registry in the world. The highly granular classification of the EPRD product database, which currently includes more than 70,000 components, is set to become the international standard. The linkage of hospital case data with specific implant component data and routine data from health insurance providers enables robust arthroplasty survival analyses. This provides hospitals, manufacturers, and the specialist community with access to specific results that contribute to improving arthroplasty quality. The registry is gaining increasing international recognition by publishing in peer-reviewed journals. An application procedure also allows "third-party" data access. Furthermore, the EPRD has also established an early warning system to detect anomalies in outcome. Software-based detection of potential implant component mismatches allows notification of hospitals concerned. In 2023, the EPRD will trial extending its data collection to include patient satisfaction surveys (i.e., patient-reported outcome measures), and subsequently to surgeon-specific data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.